Search - tctmd.com

Displaying 901 - 920 of 1084

Sort: Relevancy | Date

News Industry News

SHIELD I Trial Results Confirm St. Jude Medical HeartMate PHP Cardiac Assist Device Provides Consistent, Reliable Cardiac Support During High-Risk PCI Procedures

October 14, 2015

News Conference News TCT 2015

Cath Lab Economics: Pursuit of a Light at the End of the Tunnel

Nicole Lou

October 11, 2015

News Daily News

Revascularization May Benefit Stable CAD Patients With Unclassifiable Appropriateness Scores

Todd Neale

October 08, 2015

News Industry News

Abiomed's Impella(R) Technology Showcased at TCT 2015 With Over 25 Presentations in the Scientific Sessions

October 08, 2015

News Daily News

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

September 22, 2015

News Daily News

Mechanical Circulatory Support in TAVR Tied to Worse Outcomes, Higher Costs

Todd Neale

September 17, 2015

News Daily News

Registry Charts Trends in Mechanical Circulatory Support During PCI

L.A. McKeown

September 14, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Daily News

COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization

L.A. McKeown

September 09, 2015

News Daily News

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

August 27, 2015

News Daily News

Real-World LVAD Use Promising in Patients Otherwise Considered Too Sick for PCI

L.A. McKeown

August 24, 2015

News Daily News

CAD Location May Influence Need for Prolonged DAPT Post-PCI

Caitlin E. Cox

August 24, 2015

Presentation

Percutaneous LVAD for High-Risk PCIs:Real-World vs Clinical-Trial Experience

Presenter: Mauricio G. Cohen

August 21, 2015

News Daily News

Chronic Pacing Linked to Lower Survival After Balloon-Expandable TAVR

August 20, 2015

News Industry News

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0-LD Pre-Market Approval Supplements

August 18, 2015

News Daily News

High Troponin T Foretells Poor Outcomes in Patients With Type 2 Diabetes, Stable Heart Disease

Todd Neale

August 17, 2015

News Daily News

Staged PCI May Lower Mortality in STEMI Patients With Multivessel Disease

L.A. McKeown

August 12, 2015

News Daily News

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Yael L. Maxwell

August 12, 2015

News Daily News

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

Yael L. Maxwell

July 31, 2015

Advertisement

SHIELD I Trial Results Confirm St. Jude Medical HeartMate PHP Cardiac Assist Device Provides Consistent, Reliable Cardiac Support During High-Risk PCI Procedures

Cath Lab Economics: Pursuit of a Light at the End of the Tunnel

Revascularization May Benefit Stable CAD Patients With Unclassifiable Appropriateness Scores

Abiomed's Impella(R) Technology Showcased at TCT 2015 With Over 25 Presentations in the Scientific Sessions

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

Mechanical Circulatory Support in TAVR Tied to Worse Outcomes, Higher Costs

Registry Charts Trends in Mechanical Circulatory Support During PCI

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

Real-World LVAD Use Promising in Patients Otherwise Considered Too Sick for PCI

CAD Location May Influence Need for Prolonged DAPT Post-PCI

Percutaneous LVAD for High-Risk PCIs:Real-World vs Clinical-Trial Experience

Chronic Pacing Linked to Lower Survival After Balloon-Expandable TAVR

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0-LD Pre-Market Approval Supplements

High Troponin T Foretells Poor Outcomes in Patients With Type 2 Diabetes, Stable Heart Disease

Staged PCI May Lower Mortality in STEMI Patients With Multivessel Disease

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content